Attenuvax

Attenuvax

a trademark for an active immunizing agent (live measles virus vaccine).
References in periodicals archive ?
A study4 of 6-month-old and 15-month-old infants born to vaccine-immunized mothers demonstrated that, following vaccination with ATTENUVAX, 74% of the 6-month-old infants developed detectable neutralizing antibody (NT) titers while 100% of the 15-month-old infants developed NT.